Genentech’s first-ever DTP program in support of trumps goals and major advancement in the flu season

Image Credit: Pharmafile

Announcement 

Genentech, a valuable member of the Roche Group, launched the company’s first-ever direct-to-patient (DTP) program. The program strongly contributes to President Trump’s goal to deliver affordable medicines to American patients, specifically pointing to Xofluza (baloxavir marboxil), a once-a-day single-dose oral antiviral medication. This medication is used to treat the flu in patients aged 5 years and above, as well as for those who have contracted the flu. These efforts will help alleviate costs for individuals having no such healthcare/life insurance or having limited coverage, or those having health plans except Xofluza.

Genentech’s incorporation to launch the DTP program

Genentech is partnering with three pharmacies to provide medication, including prescriptions. The three pharmacies are Mark Cuban cost plus drug company, PBC; Alto Pharmacy powered by Fuze Health and Amazon Pharmacy. The key details in alignment with these three pharmacies' contributions proved beneficial for Genentech to perform excellently. This collaboration includes support like same-day home delivery benefit in select markets via Amazon Pharmacy and Alto Pharmacy powered by Fuze Health.

Including a new $50 cash pay option with 70% relief affordable than the list price that will be offered to eligible patients through cost plus drugs and Alto Pharmacy. For individuals demanding home delivery through mail delivery is available globally via all three pharmacies for individuals thinking of using Xofluza as a prophylaxis treatment.

The chief executive officer of Genentech, Ashley Magargee, said, “This new idea will enable convenience, same-day delivery option of our pivotal flu treatment in select US markets. Extending our distribution line for Xofluza will enable us the reach for more patients where they are willingly considering the search for their medicines.”

Genentech’s other programs

Genentech’s other programs make the medicines less expensive, involving the Xofluza coupon, which has been advanced this season. The patients who meet the eligibility criteria will pay a small amount $35, for their Xofluza prescription with $70 discount at various pharmacies, including Amazon Pharmacy and Alto Pharmacy powered by Fuze Health. This will automatically attach the manufacturer-sponsored coupon to the eligible orders.

Addressing the severity, unfortunate history, and need for affordable treatment, these programs have provided relief to American patients. The new program is paving a wave of confidence for the patients seeking suitable treatment with reduced cost and experiencing the valuable, effective treatment they deserve.